Title
Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis
Date Issued
01 October 2004
Access level
open access
Resource Type
journal article
Author(s)
Daze L.
Verdonck K.
Vandamme A.M.
Cairampoma R.
Narvarte G.
De Las Casas C.
Publisher(s)
Oxford University Press
Abstract
Background. Human T cell lymphotropic virus type 1 (HTLV-1) is associated with tropical spastic paraparesis (TSP). Peru is an area of endemicity for HTLV-1. Methods. All patients with suspected cases of TSP referred to our institute (Institute of Tropical Medicine Alexander von Humboldt, Lima, Peru) from 1989 through 2002 were interviewed and tested for HTLV-1. All patients with positive results were evaluated by an expert physician. Disease progression was defined as "rapid" if the time between TSP onset and inability to walk unaided was <2 years. Results. Among 165 patients enrolled, the symptoms and signs most frequently found were spasticity (in 97.5% of patients), hyperreflexia (95.4%), lower limb paresthesia (90.2%), pyramidal signs (82.6%), urinary complaints (82.0%), and lumbar pain (79.0%). Rapid progression was present in 21.5% of patients; mean age at TSP onset was higher among these patients than among slow progressors (P<.001). Severe spasticity, diminished vibratory sensation, and tremor were found more frequently among rapid progressors, compared with slow progressors. Conclusions. HTLV-1-associated TSP is frequently diagnosed in areas of HTLV-1-endemicity. A subgroup of patients experiences rapid disease progression.
Start page
939
End page
944
Volume
39
Issue
7
Language
English
OCDE Knowledge area
Neurociencias
Epidemiología
Medicina tropical
DOI
Scopus EID
2-s2.0-4744344801
PubMed ID
Source
Clinical Infectious Diseases
ISSN of the container
10584838
Sources of information:
Directorio de Producción Científica
Scopus